The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Foxp3 Transcription Factor Is Proapoptotic and Lethal to Developing Regulatory T Cells unless Counterbalanced by Cytokine Survival Signals
Open accessAbstract
Summary Immune tolerance requires regulatory T (Treg) cells to prevent autoimmune disease, with the transcription factor Foxp3 functioning as the critical regulator of Treg cell development and function. We report here that Foxp3 was lethal to developing Treg cells in the thymus because it induced a unique pro-apoptotic protein signature (Puma++p-Bim++p-JNK++DUSP6-) and repressed expression of pro-survival Bcl-2 molecules. However, Foxp3 lethality was prevented by common gamma chain (γc)-dependent cytokine signals that were present in the thymus in limiting amounts sufficient to support only ~1 million Treg cells. Consequently, most newly arising Treg cells in the thymus were deprived of this signal and underwent Foxp3-induced death, with Foxp3+CD25- Treg precursor cells being the most susceptible. Thus, we identify Foxp3 as a pro-apoptotic protein that requires developing Treg cells to compete with one another for limiting amounts of γc-dependent survival signals in the thymus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187 · cited 2×
“The characteristic feature of Treg cells is their expression of the forkhead family transcription factor Foxp3 (Fontenot et al., 2003; Hori et al., 2003) whose function is incompletely understood, with little known about its effects on Treg cell viability.”
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 6×
“, 2008) and Foxp3-GFP referred to Foxp3-GFP knockin mice (Bettelli et al., 2006).”
InfluentialRegulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866 · cited 2×
“Regulatory T (Treg) cells are a specialized subpopulation of CD4 T cells that prevent activation of autoreactive T cells (Josefowicz et al., 2012; Sakaguchi et al., 2008) so that animals lacking functional Treg cells develop severe autoimmunity and succumb to early death (Brunkow et al.”
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
Foxp3 occupancy and regulation of key target genes during T-cell stimulation
Marson, A., Kretschmer, K., Frampton, G. M., Jacobsen, E. S., Polansky, J. K., MacIsaac, K. D., Levine, S. S., Fraenkel, E., von Boehmer, H., & Young, R. A. (2007) · Nature · doi:10.1038/nature05478 · Cited by 724 · cited 3×
“To better understand the inhibition by Foxp3 of DUSP gene expression, we examined the promoter region of DUSP6 and found that it contained putative forkhead family consensus DNA binding sequences (Figure S2F; Marson et al., 2007).”
Influential
Cited by
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
Togashi, Y., Shitara, K., & Nishikawa, H. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0175-7 · Cited by 1,546
Maj, T., Wang, W., Crespo, J., Zhang, H., Wang, W., Wei, S., Zhao, L., Vatan, L., Shao, I., Szeliga, W., et al. (2017) · Nature Immunology · doi:10.1038/ni.3868 · Cited by 733
T cell receptor signalling in the control of regulatory T cell differentiation and function
Li, M. O., & Rudensky, A. Y. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.26 · Cited by 493
Homeostatic control of regulatory T cell diversity
Liston, A., & Gray, D. H. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3605 · Cited by 427
Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment
Kitagawa, Y., Ohkura, N., Kidani, Y., Vandenbon, A., Hirota, K., Kawakami, R., Yasuda, K., Motooka, D., Nakamura, S., Kondo, M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3646 · Cited by 379
Control of Foxp3 stability through modulation of TET activity
Yue, X., Trifari, S., Äijö, T., Tsagaratou, A., Pastor, W. A., Zepeda-Martínez, J. A., Lio, C.-W. J., Li, X., Huang, Y., Vijayanand, P., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151438 · Cited by 355
Abramson, J., & Anderson, G. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052320 · Cited by 338
Th17 Cells in Cancer: The Ultimate Identity Crisis
Bailey, S. R., Nelson, M. H., Himes, R. A., Li, Z., Mehrotra, S., & Paulos, C. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00276 · Cited by 334
Savage, P. A., Klawon, D. E. J., & Miller, C. H. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100219-020937 · Cited by 321
“However, two recent studies have challenged this notion, suggesting the existence of a second pathway in which mature CD25+Foxp3+ Treg cells develop via a CD25−Foxp3lo intermediate (81, 82).”
BackgroundResultMahmud, S. A., Manlove, L. S., Schmitz, H. M., Xing, Y., Wang, Y., Owen, D. L., Schenkel, J. M., Boomer, J. S., Green, J. M., Yagita, H., et al. (2014) · Nature Immunology · doi:10.1038/ni.2849 · Cited by 281
Thymic regulatory T cells arise via two distinct developmental programs
Owen, D. L., Mahmud, S. A., Sjaastad, L. E., Williams, J. B., Spanier, J. A., Simeonov, D. R., Ruscher, R., Huang, W., Proekt, I., Miller, C. N., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0289-6 · Cited by 225
Central CD4+ T cell tolerance: deletion versus regulatory T cell differentiation
Klein, L., Robey, E. A., & Hsieh, C.-S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0083-6 · Cited by 214
Harnessing FOXP3+ regulatory T cells for transplantation tolerance
Waldmann, H., Hilbrands, R., Howie, D., & Cobbold, S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67226 · Cited by 69
The MAPK dual specific phosphatase (DUSP) proteins: A versatile wrestler in T cell functionality
Sun, F., Yue, T.-T., Yang, C.-L., Wang, F.-X., Luo, J.-H., Rong, S.-J., Zhang, M., Guo, Y., Xiong, F., & Wang, C.-Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107906 · Cited by 59
NF-κB and Extrinsic Cell Death Pathways – Entwined Do-or-Die Decisions for T cells
Blanchett, S., Boal-Carvalho, I., Layzell, S., & Seddon, B. (2021) · Trends in Immunology · doi:10.1016/j.it.2020.10.013 · Cited by 58
Caramalho, I., Nunes-Silva, V., Pires, A. R., Mota, C., Pinto, A. I., Nunes-Cabaço, H., Foxall, R. B., & Sousa, A. E. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.11.002 · Cited by 42
Role of Cytokines in Thymic Regulatory T Cell Generation: Overview and Updates
Tang, M., Jia, F., Nan, F., Zuo, F., Yuan, Z., & Zhang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883560 · Cited by 11
Metadata
- Authors
- Tai, X., Erman, B., Alag, A., Mu, J., Kimura, M., Katz, G., Guinter, T., McCaughtry, T., Etzensperger, R., Feigenbaum, L., Singer, D. S., & Singer, A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 38
- Issue
- 6
- Pages
- 1116-1128
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2001207281
- Cited by
- 218
- References
- 6
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.